Functional and phenotypic modifications induced by IL-4, as single agent or in combination with IL-2, on PBMC preactivated in vivo by alpha-interferon + interleukin-2 therapy.

Source:http://linkedlifedata.com/resource/pubmed/id/2129798

Download in:

View as

General Info

PMID
2129798